ProfileGDS5678 / 1418945_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 97% 98% 98% 98% 99% 99% 98% 98% 98% 99% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.408898
GSM967853U87-EV human glioblastoma xenograft - Control 29.7579498
GSM967854U87-EV human glioblastoma xenograft - Control 310.485398
GSM967855U87-EV human glioblastoma xenograft - Control 49.5045197
GSM967856U87-EV human glioblastoma xenograft - Control 510.676198
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.41698
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.407598
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.424699
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.201399
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.568398
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.905398
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.145698
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.833499
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.356598